Following the appointment of the Directors, the Board is comprised of the following three classes: the term of office of the first class of directors, Class I, consists of Messrs. Gallagher and Smith and will expire at the Company’s first annual meeting of stockholders; the term of office of the second class of directors, Class II, consists of Messrs. Burns and Marathe and will expire at the Company’s second annual meeting of stockholders; and the term of office of the third class of directors, Class III, consists of Messrs. Chris Hickey and Mark Wan and will expire at the Company’s third annual meeting of stockholders.
In connection with their appointments to the Board, each Director entered into the Letter Agreement as well as an indemnity agreement with the Company in the form previously filed as Exhibit 10.1 to the Registration Statement. In addition, in October 2020, the Sponsor transferred an aggregate of 475,000 shares of Class B common stock, par value $0.0001 per share, of the Company to Mr. Hickey, Mr. Burns, Mr. Gallagher, Mr. Marathe and Mr. Smith for the same per-share price initially paid by the Sponsor. On January 11, 2021, the Company effected a 1.2:1 stock split such that Mr. Hickey, Mr. Burns, Mr. Gallagher, Mr. Marathe and Mr. Smith held an aggregate of 570,000 shares of Class B common stock as of the consummation of the IPO.
Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
Copies of the the Letter Agreement and indemnity agreements are attached as Exhibits 10.1, 10.6, 10.7, 10.8 and 10.9 hereto, respectively, and are incorporated herein by reference.
Item 5.03. | Amendments to Certificate of Incorporation or Bylaws. |
On January 11, 2021, in connection with the IPO, the Company adopted its Amended and Restated Certificate of Incorporation (the “Amended and Restated Charter”), effective the same day. The terms of the Amended and Restated Charter are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Charter is attached as Exhibit 3.1 hereto and incorporated herein by reference.
A total of $276,000,000 of the proceeds received from the IPO and the sale of the Private Placement Warrants (which amount includes $9,660,000 of deferred underwriting commissions), were placed in a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes, the funds in the trust account will not be released from the trust account until the earliest to occur of: (i) the completion of the Company’s initial business combination, (ii) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 24 months from the closing of the IPO or during any extension period that may apply as a result of an amendment to the Amended and Restated Charter, subject to applicable law, and (iii) the redemption of the Company’s public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Charter to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial business combination within 24 months from the closing of the IPO or with respect to any other provisions relating to stockholders’ rights or pre-initial business combination activity.
On January 11, 2021, the Company issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing the pricing of the IPO.
On January 14, 2021, the Company issued a press release, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K, announcing the closing of the IPO.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits